Oragenics Inc. | |
Stock Exchange | NYSE |
EPS |
$0.93 |
Market Cap |
$22.1 M |
Shares Outstanding |
46.13 M |
Public Float |
25.69 M |
Address |
4902 Eisenhower boulevard Tampa Florida 33634 United States |
Employees | - |
Website | http://www.oragenics.com |
Updated | 07/08/2019 |
Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of lantibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. |